Gli, an inhibitor of the P2X7 receptor, has been reported to suppress proliferation and invasion by promoting apoptosis in breast, ovarian, prostate, gastric, liver, and bladder cancer cells [15,16,17,51]. This evidence concerns the gene GLI1 and urinary bladder carcinoma.